- Home
- TLX vs BRKR Comparison
TLX vs BRKR Comparison
Compare TLX & BRKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TLX
- BRKR
- Stock Information
- Founded
- TLX 2015
- BRKR 1960
- Country
- TLX Australia
- BRKR United States
- Employees
- TLX N/A
- BRKR N/A
- Industry
- TLX Biotechnology: Pharmaceutical Preparations
- BRKR Biotechnology: Laboratory Analytical Instruments
- Sector
- TLX Health Care
- BRKR Industrials
- Exchange
- TLX Nasdaq
- BRKR Nasdaq
- Market Cap
- TLX 6.0B
- BRKR 5.8B
- IPO Year
- TLX N/A
- BRKR 2000
- Fundamental
- Price
- TLX $16.71
- BRKR $36.28
- Analyst Decision
- TLX Strong Buy
- BRKR Buy
- Analyst Count
- TLX 1
- BRKR 12
- Target Price
- TLX $22.00
- BRKR $63.40
- AVG Volume (30 Days)
- TLX 28.3K
- BRKR 2.7M
- Earning Date
- TLX 01-01-0001
- BRKR 05-07-2025
- Dividend Yield
- TLX N/A
- BRKR 0.53%
- EPS Growth
- TLX 798.14
- BRKR N/A
- EPS
- TLX 0.09
- BRKR 0.76
- Revenue
- TLX $484,687,790.00
- BRKR $3,366,400,000.00
- Revenue This Year
- TLX N/A
- BRKR $5.66
- Revenue Next Year
- TLX N/A
- BRKR $5.99
- P/E Ratio
- TLX $179.17
- BRKR $47.80
- Revenue Growth
- TLX 55.85
- BRKR 13.56
- 52 Week Low
- TLX $13.61
- BRKR $34.10
- 52 Week High
- TLX $30.36
- BRKR $84.90
- Technical
- Relative Strength Index (RSI)
- TLX N/A
- BRKR 36.16
- Support Level
- TLX N/A
- BRKR $35.53
- Resistance Level
- TLX N/A
- BRKR $40.37
- Average True Range (ATR)
- TLX 0.00
- BRKR 2.75
- MACD
- TLX 0.00
- BRKR 0.08
- Stochastic Oscillator
- TLX 0.00
- BRKR 27.18
About TLX Telix Pharmaceuticals Limited American Depositary Shares
Telix develops radiopharmaceuticals to manage cancer. Radiopharmaceuticals are radioisotopes bound to molecules that can target specific cells. At low doses, these drugs can bind to specific cancer cells with radiation, and then positron emission tomography imaging can accurately visualize tumors. At high doses, these drugs can selectively target and treat tumors with radiation, known as radioligand therapy. Radiopharmaceuticals are usually injected into the bloodstream. Telix has a pipeline of potential radiopharmaceuticals but currently earns most of its revenue from US sales of Illuccix, largely used as an imaging agent to visualize the spread of prostate cancer.
About BRKR Bruker Corporation
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Supercon Technologies (BEST). The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from United States.